quinoxalines has been researched along with Amyotonia Congenita in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gayathri, R; Jubie, S; Kalirajan, R | 1 |
| Dong, RG; Flavahan, NA; Flavahan, S; Krajnak, K; Welcome, D | 1 |
2 other study(ies) available for quinoxalines and Amyotonia Congenita
| Article | Year |
|---|---|
Synthesis and neuropharmacological evaluation of some novel quinoxaline 2, 3-dione derivatives.
Topics: Animals; Ethidium; Exploratory Behavior; Mannich Bases; Mice; Neuromuscular Diseases; Neuroprotective Agents; Quinoxalines; Rats | 2012 |
Acute vibration increases alpha2C-adrenergic smooth muscle constriction and alters thermosensitivity of cutaneous arteries.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Body Temperature Regulation; Brimonidine Tartrate; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Muscle, Smooth, Vascular; Neuromuscular Diseases; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Skin; Tail; Vasoconstriction; Vibration | 2006 |